Search results for "Anticoagulation"
Coding for anticoagulation as tricky as managing it
Diagnosis, lab tests and management make up the three key considerations when coding for anticoagulation management through Medicare. An expert sorts out the issues and scenarios for a variety of scenarios.
https://immattersacp.org/archives/2010/05/practice.htm
1 May 2010
Approvals for an oral anticoagulant, generic esomeprazole
This update covers the approval of an oral medication to reduce the risk of stroke and embolism in atrial fibrillation and the first generic version of esomeprazole.
https://immattersacp.org/archives/2015/04/fda.htm
1 Apr 2015
Managing DOACs in primary care
Primary care physicians play a crucial role in ongoing anticoagulation management, including educating patients about the signs of venous thromboembolism.
https://immattersacp.org/archives/2022/04/managing-doacs-in-primary-care.htm
1 Apr 2022
Task Force finds insufficient evidence on screening for afib
The U.S. Preventive Services Task Force reviewed trials published since 2017 but did not deem them strong enough to show evidence of benefit or harm.
https://immattersacp.org/weekly/archives/2022/02/01/3.htm
1 Feb 2022
Oral drug for postpartum depression approved
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/10/oral-drug-for-postpartum-depression-approved.htm
1 Oct 2023
Risk of ischemic stroke may be higher in afib patients on newer anticoagulants vs. on warfarin
The increase in stroke risk was particularly high among patients taking apixaban and dabigatran, whereas the results for rivaroxaban and edoxaban were more ambiguous.
https://immattersacp.org/weekly/archives/2018/10/23/4.htm
23 Oct 2018
Guidelines offer 28 recommendations for initial management, secondary prevention of DVT and PE
Among other recommendations, the new guidelines from the American Society of Hematology suggest offering home treatment to low-risk patients with deep venous thrombosis (DVT) or pulmonary embolism (PE).
https://immattersacp.org/weekly/archives/2020/10/20/5.htm
20 Oct 2020
Updated Beers criteria highlight medications that are risky in older patients
The American Geriatrics Society has added warfarin as a medication to avoid and urged caution with sodium-glucose cotransporter-2 inhibitors in the latest update of its guidance on prescribing for U.S. adults ages 65 years and older.
https://immattersacp.org/weekly/archives/2023/05/16/1.htm
16 May 2023
MKSAP Quiz: Preconception counseling for mitral stenosis
A 26-year-old woman seeks preconception counseling. She has a history of mitral stenosis and underwent mitral valve replacement with a tilting-disc mechanical prosthesis 5 years ago. Following a physical exam, lab studies, and electrocardiogram, what is the most appropriate anticoagulation regimen for this patient during the first trimester?
https://immattersacp.org/weekly/archives/2020/06/23/3.htm
23 Jun 2020
Apixaban associated with lower risk of GI bleeding compared to other DOACs
Apixaban users experienced similar rates of ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality as patients taking other direct oral anticoagulants (DOACs), a retrospective analysis found.
https://immattersacp.org/weekly/archives/2022/11/01/1.htm
1 Nov 2022